Results 81 to 90 of about 4,065 (123)

[Advances in research on metabolic associated fatty liver disease in 2025]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Rao HY, Zhao JM, Yu CH, Mi YQ, Wei L.
europepmc   +1 more source

[Novel advances following the integration of Baveno VII consensus definitions for the non-invasive testing of portal hypertension]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Chen JL, Yang CQ.
europepmc   +1 more source

[Liver-bone axis: novel mechanisms and strategies for MAFLD regulation]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Wang YW, Yan XZ, You H, Yang AT.
europepmc   +1 more source

[A case of segmental atrophy of the liver in children]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Qiu YL, Mao Y, Lu CL.
europepmc   +1 more source

丝裂霉素纤维蛋白胶凝胶化疗的缓释特性

Zhongshan Daxue xuebao. Yixue kexue ban, 2004
【目的】探讨丝裂霉素纤维蛋白胶凝胶(MMC/FG)化疗的缓释特性。【方法】体外释放实验中,将8mg丝裂霉素(MMC)与5mL纤维蛋白胶(FG)混合成凝胶MMC/FG,将凝胶置于50mL含纤溶酶原及尿激酶的磷酸盐缓冲液(PBS)中,在37℃恒温摇床中培养。分别于开始培养15min,2、8、24、48、72、96、120h后取0.1mLPBS作样本,测试其中的MMC质量浓度,观察MMC的释放过程。体内实验中,将MMC/FG(实验组)或单纯MMC溶液(对照组)在开腹直视下注入小鼠肝脏 ...
doaj  

[<i>Huoxue Qingjie Ling</i> alleviates bile duct ligation-induced hepatic fibrosis in rats by regulating the Sirt1-autophagy signaling pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Li C, Cui L, Cao J, Fan Y, Zhou X, Zhang S, Zuo Y.   +6 more
europepmc   +1 more source

[Clinical features and pathological scoring analysis of hepatic amyloidosis]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Gong YX, Du ZX, Yang Y, Li SS, Wang JL, Yang YF.   +5 more
europepmc   +1 more source

[Positive antinuclear antibodies suggest a high inflammatory burden phenotype: a multicenter retrospective analysis of patients with primary biliary cholangitis]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Li SS, Li RJ, Zhang Y, Ji WJ, Bao YJ, Liu HL, Gong YX, Wang YT, Tao YL, Wu ZX, Zhang Y, Zhang WH, Li W, Ye F, Yan XH, Mao TH, Liu X, Zhang K, Yang YF.   +18 more
europepmc   +1 more source

[Research progress and future prospects for artificial intelligence in the diagnosis and treatment of fatty liver disease]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Lin YY, Liu F, Rao HY.
europepmc   +1 more source

[LncRNA Meg3 expression level is negatively correlated with liver fibrosis severity in patients with Wilson disease]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Hua D, Xuan Q, Sun L, Yu Q, Wang Q, Wang T, Ma Q, Yang W, Wang H.   +8 more
europepmc   +1 more source